Go Back   AAPC Medical Coding & Billing Forums > Medical Coding > Anesthesia
Forum Rules FAQ Members List Calendar Search Today's Posts Mark Forums Read

Reply
 
Thread Tools
  #1  
Old 02-25-2012, 01:22 PM
lch lch is offline
Networker
 
Join Date: Apr 2007
Location: Nashville, TN
Posts: 37
lch is on a distinguished road
Default urine drug screen in pain management confused

I am new to pain management/anesthesia coding and am confused about the coding of urine drug tests done in our office on patient's prior to being prescribed pain meds. The lab tech does a urine "dip" qualitative drug screening test that tests for 12 different classes of drugs. Our office is billing 80101x12 units for all insurances except for Medicare, which is billed as G0434-QW x1 unit. The charge differences in these is huge. The urine sample is also being sent to an outside lab (Ameritox) to "confirm" test results and they are apparently billing the patient's insurance for the test also.. this sooo does not sound right to me.. does anyone have any input? Thanks!
__________________
Len Hales, RN, BSN, CPC
Reply With Quote
  #2  
Old 02-25-2012, 02:35 PM
j.williams2971@yahoo.com j.williams2971@yahoo.com is offline
New
 
Join Date: Apr 2007
Posts: 2
j.williams2971@yahoo.com is on a distinguished road
Default

I know what you mean, I find myself reviewing informantion over and over, you would code what your office calls for,and the lab will code their servics, and then
your office will code (if any conformaition ( X's how many found) of any drugs found in those pre drug screens. Jen
Reply With Quote
  #3  
Old 02-27-2012, 10:14 PM
dwaldman dwaldman is offline
True Blue
 
Join Date: Apr 2007
Posts: 1,090
dwaldman is on a distinguished road
Default

The non-Medicare payer should being billed 80104 with quantity one if one is billing a urine drug screen utilzing a drug test kit that is simulaneously testing multiple drugs or drug classes in a single procedure. Medicare recognizes G0434-QW for CLIA waived drug test kit that commonly used for point of care testing.

The company or reference lab that is receiving the specimen can do a qualtative test and potentially bill 80101 per drug class or G0431 depending on the instrument, test method, and complexity of the test because they are personally performed that level of testing. This does exclude the billing for initial point of care testing performed in an office setting.

Below is from AMA CPT Assistant, where it is described of an instrument that utilizes immunoassay or enzyme immunoassay that individually tests the specimen per drug class using a more complex test method. The cost of this type of test is higher and the resources required are represnted by 80101 per classes that were ordered to be tested. Whereas, a drug test kit the resources are lower in cost (ie cost of the drug test kit) and 80104 and G0434 more accurately cover these type of resources used.

CPT Assistant
Drug Testing

Qualitative assays (ie, tests that detect whether a particular analyte, constituent, or condition is present or absent) are reported with the drug testing codes. Qualitative screen analysis using a multiplexed screening kit for multiple drugs or drug classes is reported with the new CPT code 80104. This new code was established to allay confusion when reporting qualitative analysis using a multiplexed method for 2-15 drugs or drug classes (eg, multidrug screening kit). Traditionally, a chromatographic method may have been used that identified multiple drug classes during a single procedure. This was represented by code 80100, Drug screen, qualitative; multiple drug classes chromatographic method, each procedure. Methods then became available that relied upon immunoassay or enzyme assay in which an assay identified the presence or absence of drugs within a single class. Each test run was for just one class and code 80101 Drug screen, qualitative; single drug class method (eg, immunoassay, enzyme assay), each drug class described this method. More recently point of care and other testing can be used to identify multiple drug classes in a single test procedure. However, these assays do not utilize a chromatographic method, making code 80100 in appropriate to use. They may rely on immunoassays, for example. Kits are commercially available for 12 or more analytes. These test kits are often called "multiplexed" because of the ability to qualitatively assay multiple drugs simultaneously. It is effectively running multiple tests at once, in a single procedure, due to the test kit design. Prior to 2011, the reporting of qualitative testing for multiple drugs classes in a single kit was commonly reported as multiple units of code 80101 as code 80101 was not specific to a single or multiple sequential procedures. In 2010 a HCPCS code G0430 was created to describe a non chromatographic method wherein multiple drug classes were screened in a single procedure. New code 80104 represents this same procedure, more accurately reflecting the resources used in a multiplex test kit as compared to multiple runs using a single class methodology.

__________________________________________________ _____________

http://www.cms.gov/MLNMattersArticle...ads/SE1105.pdf

Effective January 1, 2011, CMS will utilize two test codes to report drug screen testing:

G0434 (Drug screen, other than chromatographic; any number of drug classes, by CLIA waived test or moderate complexity test, per patient encounter) will be used to report very simple testing methods, such as dipsticks, cups, cassettes, and cards, that are interpreted visually, with the assistance of a scanner, or are read utilizing a moderately complex reader device outside the instrumented laboratory setting (i.e., non-instrumented devices). This code is also used to report any other type of drug screen testing using test(s) that are classified as Clinical Laboratory Improvement Amendments (CLIA) moderate complexity test(s), keeping the following points in mind:
o
G0434 includes qualitative drug screen tests that are waived under CLIA as well as dipsticks, cups, cards, cassettes, etc, that are not CLIA waived

G0431 (Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter) will be used to report more complex testing methods, such as multi-channel chemistry analyzers, where a more complex instrumented device is required to perform some or all of the screening tests for the patient. Note that the descriptor has been revised for CY 2011. This code may only be reported if the drug screen test(s) is classified as CLIA high complexity test(s) with the following restrictions:
o
G0431 may only be reported when tests are performed using instrumented systems (i.e., durable systems capable of withstanding repeated use).
Reply With Quote
  #4  
Old 03-06-2012, 10:53 AM
billingchic#1 billingchic#1 is offline
Contributor
 
Join Date: Apr 2007
Posts: 16
billingchic#1 is on a distinguished road
Default

I totally agree with dwaldman. If you are using a cup you should bill 80104 QW for non-Medicare and G0434 QW for Medicare.
Reply With Quote
  #5  
Old 03-07-2012, 05:55 PM
lch lch is offline
Networker
 
Join Date: Apr 2007
Location: Nashville, TN
Posts: 37
lch is on a distinguished road
Default

Thank you guys so much for your help!! I totally understand it now
__________________
Len Hales, RN, BSN, CPC
Reply With Quote
  #6  
Old 06-12-2012, 02:38 PM
jenelite jenelite is offline
New
 
Join Date: Apr 2007
Posts: 7
jenelite is on a distinguished road
Default

If you have a screening cup that also does adulteration testing (Creatinine (CR), Glutaraldehyde (GL), Nitrate (NI), Oxidants (OX), ph (PH), Specific Gravity (SG). Can you bill for these seperately as well?
Reply With Quote
  #7  
Old 06-12-2012, 11:30 PM
dwaldman dwaldman is offline
True Blue
 
Join Date: Apr 2007
Posts: 1,090
dwaldman is on a distinguished road
Default

adulteration testing (Creatinine (CR), Glutaraldehyde (GL), Nitrate (NI), Oxidants (OX), ph (PH), Specific Gravity (SG).

__________________________________________________ ___________

I believe that the above would be inclusive to 80104 due to the fact attempting to reporting individual CPTs for the above would result in additional reimbursement for no additional resources incured to perform the adulteration testing.
Reply With Quote
Reply

Thread Tools

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off




Disclaimer: Although AAPC staff members will monitor these forums periodically, we cannot be responsible for the information posted herein, nor guarantee its accuracy. Our members may discuss various subjects related to medical coding, but none of the information should replace the independent judgment of a physician for any given health issue. Please note that the opinions expressed here do not necessarily reflect those of AAPC.

All times are GMT -6. The time now is 09:10 PM.

AAPC - Top

Powered by vBulletin® Version 3.8.1
Copyright ©2000 - 2014, Jelsoft Enterprises Ltd.
Copyright ©2014, AAPC